576 related articles for article (PubMed ID: 28695752)
1. Stabilization of protein-protein interactions in drug discovery.
Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of Protein-Protein Interactions in chemical biology and drug discovery.
Bier D; Thiel P; Briels J; Ottmann C
Prog Biophys Mol Biol; 2015 Oct; 119(1):10-9. PubMed ID: 26093250
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of protein-protein interactions by small molecules.
Giordanetto F; Schäfer A; Ottmann C
Drug Discov Today; 2014 Nov; 19(11):1812-1821. PubMed ID: 25173701
[TBL] [Abstract][Full Text] [Related]
4. New Compound Classes: Protein-Protein Interactions.
Ottmann C
Handb Exp Pharmacol; 2016; 232():125-38. PubMed ID: 26489828
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
Thiel P; Kaiser M; Ottmann C
Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
[TBL] [Abstract][Full Text] [Related]
6. Natural products used as a chemical library for protein-protein interaction targeted drug discovery.
Jin X; Lee K; Kim NH; Kim HS; Yook JI; Choi J; No KT
J Mol Graph Model; 2018 Jan; 79():46-58. PubMed ID: 29136547
[TBL] [Abstract][Full Text] [Related]
7. A minimalist fragment approach for the design of natural-product-like synthetic scaffolds.
Genis D; Kirpichenok M; Kombarov R
Drug Discov Today; 2012 Nov; 17(21-22):1170-4. PubMed ID: 22659098
[TBL] [Abstract][Full Text] [Related]
8. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface.
Bier D; Bartel M; Sies K; Halbach S; Higuchi Y; Haranosono Y; Brummer T; Kato N; Ottmann C
ChemMedChem; 2016 Apr; 11(8):911-8. PubMed ID: 26644359
[TBL] [Abstract][Full Text] [Related]
9. Focusing on shared subpockets - new developments in fragment-based drug discovery.
Abdelraheem EM; Camacho CJ; Dömling A
Expert Opin Drug Discov; 2015; 10(11):1179-87. PubMed ID: 26296101
[TBL] [Abstract][Full Text] [Related]
10. Design of Drug-Like Protein-Protein Interaction Stabilizers Guided By Chelation-Controlled Bioactive Conformation Stabilization.
Bosica F; Andrei SA; Neves JF; Brandt P; Gunnarsson A; Landrieu I; Ottmann C; O'Mahony G
Chemistry; 2020 Jun; 26(31):7131-7139. PubMed ID: 32255539
[TBL] [Abstract][Full Text] [Related]
11. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
Liu M; Quinn RJ
Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
[No Abstract] [Full Text] [Related]
12. Protein-protein interaction inhibitors: advances in anticancer drug design.
Ferreira LG; Oliva G; Andricopulo AD
Expert Opin Drug Discov; 2016 Oct; 11(10):957-68. PubMed ID: 27554357
[TBL] [Abstract][Full Text] [Related]
13. Applied metabolomics in drug discovery.
Cuperlovic-Culf M; Culf AS
Expert Opin Drug Discov; 2016 Aug; 11(8):759-70. PubMed ID: 27366968
[TBL] [Abstract][Full Text] [Related]
14. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
Shin WH; Christoffer CW; Kihara D
Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
[TBL] [Abstract][Full Text] [Related]
15. Targeting protein-protein interactions for therapeutic intervention: a challenge for the future.
Zinzalla G; Thurston DE
Future Med Chem; 2009 Apr; 1(1):65-93. PubMed ID: 21426071
[TBL] [Abstract][Full Text] [Related]
16. Importance of Rigidity in Designing Small Molecule Drugs To Tackle Protein-Protein Interactions (PPIs) through Stabilization of Desired Conformers.
Lawson ADG; MacCoss M; Heer JP
J Med Chem; 2018 May; 61(10):4283-4289. PubMed ID: 29140691
[TBL] [Abstract][Full Text] [Related]
17. Fragment-based Differential Targeting of PPI Stabilizer Interfaces.
Guillory X; Wolter M; Leysen S; Neves JF; Kuusk A; Genet S; Somsen B; Morrow JK; Rivers E; van Beek L; Patel J; Goodnow R; Schoenherr H; Fuller N; Cao Q; Doveston RG; Brunsveld L; Arkin MR; Castaldi P; Boyd H; Landrieu I; Chen H; Ottmann C
J Med Chem; 2020 Jul; 63(13):6694-6707. PubMed ID: 32501690
[TBL] [Abstract][Full Text] [Related]
18. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
[TBL] [Abstract][Full Text] [Related]
19. Stabilization of protein-protein interaction complexes through small molecules.
Zarzycka B; Kuenemann MA; Miteva MA; Nicolaes GAF; Vriend G; Sperandio O
Drug Discov Today; 2016 Jan; 21(1):48-57. PubMed ID: 26434617
[TBL] [Abstract][Full Text] [Related]
20. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
Gul S; Hadian K
Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
